About Francescopalo Borriello
Form D filings for Alloplex Biotherapeutics in 2023 list Francescopalo Borriello as chief executive officer.
Francescopalo Borriello first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Francescopalo Borriello in the role, so the role may have started earlier or lasted longer.